chr10-110821884-C-A
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001134363.3(RBM20):c.3265C>A(p.Pro1089Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000121 in 1,551,734 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P1089A) has been classified as Benign.
Frequency
Consequence
NM_001134363.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBM20 | NM_001134363.3 | c.3265C>A | p.Pro1089Thr | missense_variant | 11/14 | ENST00000369519.4 | NP_001127835.2 | |
RBM20 | XM_017016103.3 | c.3100C>A | p.Pro1034Thr | missense_variant | 11/14 | XP_016871592.1 | ||
RBM20 | XM_017016104.3 | c.2881C>A | p.Pro961Thr | missense_variant | 11/14 | XP_016871593.1 | ||
RBM20 | XM_047425116.1 | c.2881C>A | p.Pro961Thr | missense_variant | 11/14 | XP_047281072.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RBM20 | ENST00000369519.4 | c.3265C>A | p.Pro1089Thr | missense_variant | 11/14 | 1 | NM_001134363.3 | ENSP00000358532.3 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152206Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000288 AC: 45AN: 156498Hom.: 1 AF XY: 0.000362 AC XY: 30AN XY: 82954
GnomAD4 exome AF: 0.000124 AC: 174AN: 1399410Hom.: 2 Cov.: 33 AF XY: 0.000167 AC XY: 115AN XY: 690210
GnomAD4 genome AF: 0.0000853 AC: 13AN: 152324Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74488
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 02, 2013 | p.Pro1089Thr (CCC>ACC): c.3265 C>A in exon 11 of the RBM20 gene (NM_001134363.1). The Pro1089Thr variant in the RBM20 gene has not been reported as a disease-causing mutation or as a benign polymorphism to our knowledge. Pro1089Thr was not observed in approximately 2000 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Although Pro1089Thr results in a non-conservative amino acid substitution of a non polar Proline with a polar Threonine, this substitution occurs at a position that is not well conserved across species. Consequently, in silico analysis predicts Pro1089Thr is benign to the protein structure/function. Only one mutation in a nearby residue (Pro1081Arg) has been reported in association with DCM (Refaat M et al., 2012). With the clinical and molecular information available at this time, we cannot definitively determine if Pro1089Thr is a disease-causing mutation or a rare benign variant. The variant is found in DCM panel(s). - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 24, 2014 | Pro1089Thr in exon 11 of RBM20: This variant is not expected to have clinical si gnificance due to a lack of conservation across species, including mammals. Of n ote, 5 mammals have a threonine (Thr) at this position despite high nearby amino acid conservation. In addition, computational analyses (AlignGVGD and PolyPhen2 ) do not suggest a high likelihood of impact to the protein. - |
Dilated cardiomyopathy 1DD Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 25, 2016 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at